Table 6. Clinical trials with Temsirolimus in head and neck cancer patients.
Compound | Combination | Phase | State | NCT number |
---|---|---|---|---|
Temsirolimus | Paclitaxel + Carboplatin | 1/2 | Not yet recruiting | NCT01016769 |
/ | 2 | Completed | NCT01172769 | |
/ | unknown | Completed | NCT00195299 | |
Cetuximab | 2 | Completed | NCT01256385 | |
Erlotinib | 2 | Completed | NCT01009203 | |
Cetuximab + Cisplatin + RT | Pilot | Withdrawn | NCT01326468 | |
Cetuximab + Cisplatin | 1/2 | Terminated | NCT01015664 |
RT: Radiotherapy, NCT: Number clinicaltrials.gov identifier.